| Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine M Prendecki, C Clarke, J Brown, A Cox, S Gleeson, M Guckian, P Randell, ... The Lancet 397 (10280), 1178-1181, 2021 | 343 | 2021 |
| Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression M Prendecki, C Clarke, H Edwards, S McIntyre, P Mortimer, S Gleeson, ... Annals of the rheumatic diseases 80 (10), 1322-1329, 2021 | 233 | 2021 |
| Persistence of HIV-1 transmitted drug resistance mutations H Castro, D Pillay, P Cane, D Asboe, V Cambiano, A Phillips, DT Dunn, ... The Journal of infectious diseases 208 (9), 1459-1463, 2013 | 124 | 2013 |
| Factor XIIIa binding to activated platelets is mediated through activation of glycoprotein IIb-IIIa AD Cox, DV Devine | 85 | 1994 |
| Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection CL Clarke, M Prendecki, A Dhutia, J Gan, C Edwards, V Prout, ... Kidney international 99 (6), 1470-1477, 2021 | 83 | 2021 |
| Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients M Prendecki, T Thomson, CL Clarke, P Martin, S Gleeson, RC De Aguiar, ... The Lancet 398 (10310), 1482-1484, 2021 | 67 | 2021 |
| A defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorder R Hardisty, D Pidard, A Cox, T Nokes, C Legrand, C Bouillot, ... | 48 | 1992 |
| Telbivudine has activity against HIV-1 E Low, A Cox, M Atkins, M Nelson Aids 23 (4), 546-547, 2009 | 44 | 2009 |
| ADP causes partial degranulation of platelets in the absence of aggregation SL Janes, DJ Wilson, AD Cox, NAF Chronos, AH Goodall British journal of haematology 86 (3), 568-573, 1994 | 44 | 1994 |
| Evidence of self-sustaining drug resistant HIV-1 lineages among untreated patients in the United Kingdom JL Mbisa, E Fearnhill, DT Dunn, D Pillay, D Asboe, PA Cane, ... Clinical Infectious Diseases 61 (5), 829-836, 2015 | 40 | 2015 |
| Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients T Thomson, M Prendecki, S Gleeson, P Martin, K Spensley, RC De Aguiar, ... EClinicalMedicine 53, 2022 | 37 | 2022 |
| The effect of recombinant IgG antibodies against the leucine-33 form of the platelet β3 integrin (HPA-1a) on platelet function L Joutsi-Korhonen, S Preston, PA Smethurst, M IJsseldijk, ... Thrombosis and haemostasis 91 (04), 743-754, 2004 | 28 | 2004 |
| HIV-1 Viral Replication below 50 Copies/ml in Patients on Antiretroviral Therapy is not associated with CD8+ T-cell Activation A Steel, AE Cox, MH Shamji, L John, M Nelson, DC Henderson, FM Gotch, ... Antiviral therapy 12 (6), 971-976, 2007 | 27 | 2007 |
| Morphological Tumor Markers: General Aspects and Diagnostic Relevance G Seifert, M Altmannberger, R Berndt, P Brandtzaeg, J Caselitz, TM Chu, ... Springer, 1987 | 20 | 1987 |
| Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: a … P Martin, S Gleeson, CL Clarke, T Thomson, H Edwards, K Spensley, ... The Lancet Regional Health–Europe 21, 2022 | 15 | 2022 |
| Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study DI Dolling, DT Dunn, KA Sutherland, D Pillay, JL Mbisa, CM Parry, ... Journal of Antimicrobial Chemotherapy 68 (10), 2339-2343, 2013 | 15 | 2013 |
| Activation-specific neo-antigens on platelets detected by monoclonal antibodies AD Cox, AH Goodall Biotechnology of plasma proteins 58, 194-199, 1991 | 15 | 1991 |
| Comparison of immunogenicity between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in a large haemodialysis population CL Clarke, P Martin, S Gleeson, T Thomson, H Edwards, P Mortimer, ... Medrxiv, 2021.07. 09.21260089, 2021 | 13 | 2021 |
| Virological failure and development of new resistance mutations according to CD 4 count at combination antiretroviral therapy initiation S Jose, K Quinn, D Dunn, A Cox, C Sabin, S Fidler, ... HIV medicine 17 (5), 368-372, 2016 | 9 | 2016 |
| Phenotypic and functional characterization of pro-aggregatory platelet mAb: subsets of CD9, CD41 and CD36 MJ Powling, AD Cox, J Higgins, RM Hardisty, AH Goodall Leukocyte Tvoing m White Cell Differentiation m. eds. Knapp, W., Dorken, B …, 1989 | 8 | 1989 |
